The technology group Körber is pleased to announce that it has been named a Leader in the 2021 Gartner Magic Quadrant for Manufacturing Execution Systems (MES) for its market leading Werum PAS-X MES for pharmaceutical, biotech and cell & gene therapy manufacturing.
Körber joins the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL), a community of biopharma manufacturers who are striving to do groundbreaking research in the field of big data, cell & gene and others to develop manufacturing capabilities in the USA.
Werum PAS-X Savvy, the leading real-time bioprocess data analytics software previously known as inCyght, provides a user-friendly way to ensure data integrity in the pharmaceutical and biopharmaceutical development as well as for CMC activities.
With almost 900 registrants from 160 different pharmaceutical and biotech companies from 45 countries around the globe, Connext celebrated a convincing start as a virtual software conference for the pharmaceutical industry.
The new subsidiary of Körber’s Business Area Pharma in Dublin enjoys growing demand for its integrated solutions for pharmaceutical and biotech production in the UK and Ireland. From Dublin, Körber offers full project services to its customers with good coordination across all competencies and products in pharma. Customers benefit by dealing with one organization responsively and locally.
The PAS-X MES software experts of Körber’s Business Area Pharma have established a new Principal Consulting & Client Advisory team. Pharmaceutical and biotech manufacturers benefit from new, value-adding PAS-X MES services by Werum Solutions on their digital transformation journey.
Users of Werum PAS-X MES can now benefit from an extended range of biometric authentication methods such as iris scan, fingerprint and facial recognition. To this end, the software experts of Körber’s Business Area Pharma have entered into a global collaboration with Integral Biometrics.
In the coming weeks we will be sharing many resources around manufacturing personalized medicines including e-books, web seminars, white papers and presentations to educate the cell and gene community.
Körber is proud to announce its membership with the Alliance for Regenerative Medicine (ARM). ARM is the leading international advocacy organization committed to realizing the promise of regenerative medicines and advanced therapies. The Körber Business Area Pharma is dedicated to supporting regenerative medicine by working with ARM, continuously innovating its digital solutions for the cell and gene therapy industry.
Körber and Walvax Biotechnology have reached an agreement to implement Werum PAS-X MES, the world’s leading manufacturing execution system (MES) for pharma, biotech and cell & gene therapy manufacturing, in their Yuxi plant for vaccine production. With the introduction of PAS-X MES, Walvax takes a key step in initiating their digital journey.
PAS-X Manufacturing Execution System awarded with the "Best Bioprocessing Supplier Award: Automation – Software" for the second consecutive year at the Annual Biologics Manufacturing Asia 2020 conference
PAS-X MES implementation at manufacturing site in Palembang, South Sumatra, Indonesia / Full integration of level 4 and 2 systems / Digitization of manufacturing processes helps Dexa Medica to become a data-driven organization
Manufacturing Execution Systems (MES) become more mission-critical / Digital processes enable pharma and biotech companies to fulfill their system-relevant functions / Werum executes MES projects remotely
Life-science customers benefit from scalable and supplementary services during MES design and implementation of their PAS-X MES / SpiraTec becomes “PAS-X Endorsed Service Partner” for DACH region and Europe
Full integration into Werum’s PAS-X Manufacturing Execution System / Out-of-the-box solution with Nymi Band / Secure operator authentication on the pharma and biotech shopfloor / Increased data integrity and production efficiency
Werum releases new PAS-X 3.2 version / Global availability for biopharmaceutical and cell & gene therapy customers from 2020 on / New and improved functionality and technologies / Enabling the fully networked, automated and smart Pharma 4.0 factory